Application Information

This drug has been submitted to the FDA under the reference 204275/001.

Names and composition

"BREO ELLIPTA" is the commercial name of a drug composed of FLUTICASONE FUROATE and VILANTEROL TRIFENATATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
204275/001 BREO ELLIPTA FLUTICASONE FUROATE; VILANTEROL TRIFENATATE POWDER/INHALATION 0.1MG per INH and EQ 0.025MG BASE per INH
204275/002 BREO ELLIPTA FLUTICASONE FUROATE; VILANTEROL TRIFENATATE POWDER/INHALATION 0.2MG per INH and EQ 0.025MG BASE per INH

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
204275/001 BREO ELLIPTA FLUTICASONE FUROATE; VILANTEROL TRIFENATATE POWDER/INHALATION 0.1MG per INH and EQ 0.025MG BASE per INH
204275/002 BREO ELLIPTA FLUTICASONE FUROATE; VILANTEROL TRIFENATATE POWDER/INHALATION 0.2MG per INH and EQ 0.025MG BASE per INH

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved